We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Greaves Brewster LLP boasts attorneys spread across the UK in Cheddar, London, Cardiff, Nottingham, and Bristol, all of whom handle the preparation, filing, prosecution, and management of patent applications and portfolios. Another key area of activity for the group is representation in opposition and appeal proceedings before the EPO, working with a client base comprising a variety of companies from the life sciences, chemistry, engineering, and physics sectors. Medical device technology is a particular area of strength for Rachel Wallis, in addition to her expertise in the life sciences sector, while Jakob Bumke is notable in the chemistry and engineering industry. Antibody and vaccine technology are key areas of expertise for David Spinner.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The patent attorney team at Greaves Brewster offers excellent quality of attorneys with deep industry knowledge and bench strength. They are very personable, commercial and provide excellent client care. They leverage use of technology efficiently. I have collaborated with them on multiple matters for clients and they never disappoint.’

  • ‘Rachel Wallis is critical to the continuing success and growth of Greaves Brewster. She ensures consistency of client management, quality of work product and approach across both the patent and trade mark practices. I consider her a key trusted adviser. Her attention to client care and commercial astuteness is one of the reasons why I go back to her again and again.'

Abbreviated data is displayed for this firm.

Key clients

  • Sigma-Aldrich Co. LLC
  • P2i Ltd
Abbreviated data is displayed for this firm.

Work highlights

  • Advised Merus N.V. on its PCT applications into national and regional phases in over 65 countries and regions and subsequent prosecution in a multi-billion-dollar market.
  • Assisted Theragnostics Limited and Ariceum Therapeutics GmbH with a high-value patent application in the US to ensure a grant which, through associated licensing, triggered significant royalty payments to the client.
Abbreviated data is displayed for this firm.